Search by Drug Name or NDC
NDC 50580-0791-02 Childrens Zyrtec 10 mg/1 Details
Childrens Zyrtec 10 mg/1
Childrens Zyrtec is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Johnson & Johnson Consumer Inc.. The primary component is CETIRIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Cetirizine injection is used to treat acute urticaria in adults and children 6 months of age or older. Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 50580-0791-02Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Cetirizine Injection
Product Information
NDC | 50580-0791 |
---|---|
Product ID | 50580-791_0e939452-59b2-27fc-e063-6394a90a780c |
Associated GPIs | |
GCN Sequence Number | 053981 |
GCN Sequence Number Description | cetirizine HCl TAB CHEW 10 MG ORAL |
HIC3 | Z2Q |
HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
GCN | 21771 |
HICL Sequence Number | 006544 |
HICL Sequence Number Description | CETIRIZINE HCL |
Brand/Generic | Brand |
Proprietary Name | Childrens Zyrtec |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Cetirizine hydrochloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/1 |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Labeler Name | Johnson & Johnson Consumer Inc. |
Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021621 |
Listing Certified Through | 2025-12-31 |
Package
NDC 50580-0791-02 (50580079102)
NDC Package Code | 50580-791-02 |
---|---|
Billing NDC | 50580079102 |
Package | 8 BLISTER PACK in 1 CARTON (50580-791-02) / 6 TABLET, CHEWABLE in 1 BLISTER PACK |
Marketing Start Date | 2023-01-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |